Burden, A.M. http://orcid.org/0000-0001-7082-8530
Tanaka, Y. http://orcid.org/0000-0002-0807-7139
Xu, L.
Ha, Y.-C. http://orcid.org/0000-0002-6249-0581
McCloskey, E. http://orcid.org/0000-0003-0177-8140
Cummings, S.R. http://orcid.org/0000-0001-8808-260X
Glüer, C.C. http://orcid.org/0000-0003-3539-8955
Funding for this research was provided by:
Swiss Federal Institute of Technology Zurich
Article History
Received: 18 October 2020
Accepted: 18 November 2020
First Online: 10 December 2020
Compliance with ethical standards
:
: AMB has no conflicts of interest to declare. YT has received speaking fees and/or honoraria from Daiichi-Sankyo, Astellas, Chugai, Eli Lilly, Abbvie, YL Biologics, Bristol-Myers, Takeda, Mitsubishi-Tanabe, Novartis, Eisai, Janssen, and Teijin. He has also received research grants from Asahi-Kasei, Mitsubischi-Tanabe, Chugai, Takeda, Sanofi, Bristol-Myers, UCB, Daiichi-Sankyo, Eisai, and Ono. LX has no conflicts of interest to report. Y-CH has no conflicts of interest to report. EM reports grants and/or personal fees from Amgen, Consilient Health, Fresenius Kabi, MSD, Novartis, Roche, AgNovos, Internis, and REDX Pharma outside the submitted work. SRC reports consulting fees from Amgen, Radius, and Myovant and grants support and speaking fees from Amgen. CCG reports consulting fees from AgNovos Healthcare and Mindways Software, Inc. and research funding from AgNovos.
: Not applicable